Archived - New Safety Information on the Use of DEPO-PROVERA (medroxyprogesterone acetate suspension for injection, 150 mgIM) associated with Bone Mineral Density Changes -Pfizer Canada Inc.
Issued June 30, 2005
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker